ecancer

Highlights of the p-medicine project

2 Sep 2015

The p-medicine project and ECRIN

Jacques Demotes - ECRIN

2 Sep 2015

Banking on biomarkers – improving the diagnosis of early stage NSCLC

Dr Harvey Pass - New York University Langone Medical Center, New York, USA

6 Jul 2015

Moving precision medicine for lung cancer into the adjuvant setting

Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA

6 Jul 2015

SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC

Prof Razelle Kurzrock - University of California, San Diego, USA

3 Jul 2015

SPECTAlung: improving clinical trial access for patients with thoracic tumours

Dr Jessica Menis and Dr Benjamin Besse

3 Jul 2015

PDL1 expression in thymic tumours

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA

16 Jun 2015

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

Dr Emiliano Calvo - START Madrid, Madrid, Spain

12 Jun 2015

Round-up of the latest research on lung cancer

Dr James Spicer - Guy's Hospital, London, UK

9 Jun 2015

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma

Prof Yilong Wu - President of the Chinese Society of Clinical Oncology

5 Jun 2015

Developments in clinical trials and health information technology that will improve targeted therapies for patients

Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA

1 Jun 2015

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer

Dr Ross Camidge - University of Colorado, Denver, USA

31 May 2015

More from ecancer